SLC39A10 and breast cancer: Knockdown of ZIP10 in invasive and metastatic breast cancer cell lines (MDA-MB-231 and MDA-MB-435S) or treatment of the cells with a cell-permeable zinc chelator suppressed cell migration suggesting that ZIP10 stimulated migratory behaviour through its zinc transporting activity [28].